Trial · NCT01268683
Registered outcomes20
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 20 of 20
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Rate of Enrollment | Day 1 | The number of months to enroll 10 participants. |
| Primary | Percentage of Enrolled Participants to Screened Participants | Day 1 | |
| Primary | Percentage of Participants Completing 90-Day Follow-Up | Day 90 | |
| Primary | Percentage of Dose Reductions/ Dose Suspensions | Up to Day 3 | |
| Primary | Percentage of Participants With All Four MRI Assessments Per Protocol | Up to Day 3 | |
| Primary | Number of MRI Assessments Per Participant | Up to Day 3 | |
| Primary | Percentage of Participants Requiring One or More Hypoglycemia Treatments | Up to Day 4 | |
| Primary | Percentage of Participants With Pre-specified Adverse Events Associated With Glyburide According to Protocol | Up to Day 4 | |
| Secondary | Number of Participants With Adverse Events and Serious Adverse Events | Up to Day 90 | Adverse Events (AE's) of special interest (cardiac events, difficulty controlling blood sugar, liver problems, and blood disorders, including anemia) will be followed for 30 days and all Severe Adverse Events (SAE's) will be followed for 90 days. SAE's and AE's were reviewed, and the number of participants with unanticipated adverse events, or drug-related SAE's were assessed. |
| Secondary | Infarcted Hemisphere Volume | Baseline, Day 1, Day 2, and Day 3 | |
| Secondary | Absolute Diffusion Weighted Imaging (DWI) Lesion Volume | Baseline, Day 1, Day 2, and Day 3 | |
| Secondary | Change From Baseline in DWI Lesion Volume | Baseline, Day 1, Day 2, and Day 3 (Day 3 reported) | |
| Secondary | Midline Shift | Baseline, Day 1, Day 2, and Day 3 | |
| Secondary | Ipsilateral Ventricle Volume | Baseline, Day 1, Day 2, and Day 3 | |
| Secondary | Frequency of Hemorrhagic Events | Day 1, Day 2, and Day 3 | |
| Secondary | National Institute of Health Stroke Scale (NIHSS) Score | Baseline, Day 1, Day 2, Day 3, and Day 7 | The NIHSS is composed of 11 categories, each of which is scored between 0 and 4. A score of 0 indicates normal function, a higher score indicates more impairment. Category scores are summed to generate the total NIHSS score (possibles scores range from 0-42). |
| Secondary | Glasgow Coma Scale (GCS) Score | Baseline, Day 1, Day 2, Day 3, and Day 7 | The GCS is scored on a scale between 3 and 15 (3 = the worst, and 15 = best). It is composed of three parameters : Best Eye Response (scored on a scale of 1-4), Best Verbal Response (scored on a scale of 1-5), Best Motor Response (scored on a scale of 1-6) |
| Secondary | Full Outline of UnResponsiveness (FOUR) Score | Baseline, Day 1, Day 2, Day 3, and Day 7 | The FOUR Score is a 17-point scale (with potential scores ranging from 0 - 16). Decreasing FOUR Score is associated with worsening level of consciousness. The FOUR Score assesses four domains of neurological function: eye responses, motor responses, brainstem reflexes, and breathing pattern. |
| Secondary | Number of Participants Requiring Decompressive Craniectomy (DC) | Up to Day 90 | |
| Secondary | Number of Participants With a Modified Rankin Scale (mRS) Score ≤ 4 | Day 30, Day 90 | The mRS scale runs from 0-6, the scoring is as follows: 0 - No symptoms, 1 - No significant disability, 2 - Slight disability, 3 - Moderate disability, 4 - Moderately severe disability, 5 - Severe disability, 6 - Dead |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01268683/registered